Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-004176

CVP, JAPAC sold 300 shares at $70.61 ($21,183)

  • CVP, JAPAC acquired 300 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, JAPAC

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-08 Exercise or conversion : show line 1 in the form 10b5-1 +300 $45.28 $13,583 23,163.11 D
2025-04-08 Sale : show line 2 in the form 10b5-1 −300 $70.61 $21,183 22,863.11 D
Open-market sales · 300 sh · avg $70.61 · $21,183

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-08 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −300 330 D
Loading xslF345X05/doc4.xml…